At this year’s South by Southwest (SXSW) conference in Austin, Rice researchers explored how to close that gap, whether by rethinking how climate change is communicated or by accelerating scientific discovery through artificial intelligence.
Rice researchers and collaborators induced heart cells to increase mitochondria production to optimal levels, opening a path toward a new therapy for heart failure.
A team of researchers led by Rice bioengineer Omid Veiseh has been awarded up to $18.2 million in funding from the Advanced Research Projects Agency for Health to develop a first-of-its-kind regenerative treatment aimed at restoring damaged lymphatic vessels and potentially curing lymphedema, a condition that affects more than 10 million Americans.
More than 600 investors, entrepreneurs and industry leaders gathered at Rice Business Nov. 11 for the 14th annual Texas Life Science Forum, co-hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship. The event highlighted Houston’s growing leadership in life science innovation, commercialization and venture investment.
Rice’s Baker Institute for Public Policy has named Dr. Heidi Russell as the director of the Center for Health Policy. She is also appointed as the L.E. and Virginia Simmons Senior Fellow in Health Policy and the Huffington Fellow in Child Health Policy. She will step into these roles at the Baker Institute Oct. 13.
The Future of AI and Behavioral Health Workshop, a joint effort of Rice and UTHealth Houston, explored the intersection of artificial intelligence and behavioral health and served to spotlight the launch of UTHealth Houston’s new School of Behavioral Health Sciences.
Ahead of the Houston Methodist-Rice University Digital Health Institute Summit Oct.8, Rice News spoke with institute leadership about the institute’s vision, its distinctive assets and the opportunities it opens for the future of health care.
Biotechnology Innovation Organization president and CEO John F. Crowley visited Rice as part of a tour highlighting regional biotech hubs across the country.
Researchers at Rice and collaborators have developed a wireless network of miniature bioelectric implants that could transform treatment for heart failure, spinal cord injury and other chronic conditions. The system would integrate with patient anatomy easier than conventional medical implants, eliminating the need for batteries and invasive wiring.
CHHAIN, supported by a $500,000 NEH grant, will serve as a central hub for exploring how humanities-based insights, particularly those grounded in ethics, history and patient narratives, can shape the future of responsible AI in health care.
A new report from Rice’s Baker Institute for Public Policy compares the cost of receiving care at Baylor St. Luke’s Medical Center, Houston Methodist Hospital and Memorial Hermann-Texas Medical Center using insurers’ price transparency files. The data suggests that employers can use the new information to achieve significant savings by choosing insurers that have negotiated lower prices with the major hospitals and by encouraging workers to choose lower priced hospitals within their insurance plan.
Rice's Synthesis X Center and Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center have awarded the second offering of a two-year seed grant program.
Rice bioengineer Mario Escobar has won a Transformational Project Award from the American Heart Association to develop a new therapy for heart failure.
The Digital Health Institute — a recently launched joint initiative between Rice University and Houston Methodist — has appointed Pothik Chatterjee as its executive director, effective May 1.